Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed that a conference call for the Indian and overseas analysts has been arranged by its management to discuss the Company's financial results for Quarter / Half Year ended September 30, 2018 on Monday, November 12, 2018 at 2.30 P.M. local time. Dr. A. Velumani, Chairman & Managing Director, A. Sundararaju, Executive Director & CFO, Sachin Salvi, General Manager- Finance, and Anand Velumani, Director, Nueclear I Healthcare, will represent the Company. Dial-in details are given in the copy of enclosed Invite of Prabhudas Lilladher, who is organizing the conference call.
The above information is a part of company’s filings submitted to BSE.
